Effect of renvastinib on the level of AFP-L3, AFP, DCP and immune function in patients with hepatocellular carcinoma after radiofrequency ablation
| Just accepted | Online first | Issue | Totals | |
|---|---|---|---|---|
| HTML pages views | 0 | 0 | 34 | 34 |
| PDF downloads | 0 | 0 | 9 | 9 |
Citation counts are provided from Web of Science and CrossRef. The counts may vary by service, and are reliant on the availability of their data. Counts will update daily once available.
|